Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Advantex Marketing International Inc C.ADX

Alternate Symbol(s):  ATXMF

Advantex Marketing International Inc. is a Canada-based company, which provides working capital to merchants. The Company also provides specialized marketing programs that enable members of Aeroplan to earn Aeroplan points at participating merchants. It operates through two segments: Merchant cash advance (MCA) program and Aeroplan program. In the MCA program, the Company provides merchants... see more

CSE:ADX - Post Discussion

Advantex Marketing International Inc > ADXs Extreme MAGA(Joe) And White Male Victim(Hunter)
View:
Post by Loony on Oct 12, 2022 8:54pm

ADXs Extreme MAGA(Joe) And White Male Victim(Hunter)

https://ca.finance.yahoo.com/quote/ADXS/community?p=ADXS

Terrible ADX companies=ADXs

Glta MAGA shareholders. LOL
Comment by Loony on Oct 12, 2022 9:45pm
Both AdXs had early June/22 crashes.
Comment by Loony on Oct 12, 2022 10:50pm
03Jun '2022 Advaxis, Inc. Announces 1-for-80 Reverse Stock Split MONMOUTH JUNCTION, N.J. , June 03, 2022 (GLOBE NEWSWIRE) -- Advaxis, Inc. (OTCQX: ADXS) (the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced that it has filed a Certificate of Amendment to the Amended and Common Shares to Commence ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities